Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: License purchase rate Vs Patent expiration dates

License purchase rate Vs Patent expiration dates

posted on Jul 15, 2008 11:25AM

Something big has to happen in terms of the license sales rate if we are to capture a majority of the sales that are possible - before patent expiration.

At a rate of 10 per Q we'd have 280 sales in 7 years. We have until 2015, less than 7 years, remaining on the patents. The total sales opportunities are in the 400 range from what I've read.

The "something big" must be a favorable outcome of the Patent re-examinations for 148, 336, 584 and 749. What's the odds of further delays (more litigation or other PTO hoops)? 'We've seen delay after delay - additional delays would be very discouraging.

Results in the most recently completed two Qs suggest that 10 sales per Q is within reach. At this time it still seems possible for PTSC to be successful. I think it boils down to the question, "can TPL avoid more legal delays or at least avoid drawn out sales draughts"? It's Possible.



3
Jul 16, 2008 05:23AM
5
Jul 16, 2008 05:36AM
Share
New Message
Please login to post a reply